- Di processo
- The meeting will gather international experts to discuss the most recent advances in immune pathways, mucosal–joint and neuro–immune communication, and cellular and molecular targets. This year’s edition introduces an expanded focus on artificial intelligence and multi-omics integration, enabling a transition from population-based to individualized medicine. Particular attention will also be devoted to emerging therapeutic frontiers, from metabolic and stromal immunity to innovative biologics, small molecules, and potential cell-based or tolerogenic approaches. The congress will emphasize the clinical dimension — re-evaluating disease phenotypes, long-term outcomes, fatigue, and the patient experience. The congress aims to provide a comprehensive and forward-looking perspective on the evolving of systemic inflammatory diseases, showcasing how next-generation science, technology, and clinical reasoning can converge to achieve precision, personalization, and prevention in rheumatology